期刊文献+

丹红注射液对不稳定型心绞痛患者血流动力学和高敏C反应蛋白的影响 被引量:10

Affection of Hemorrheology and Hyper-sensitive C-RP of Danhong Injection on Unstable Angina
下载PDF
导出
摘要 目的探讨丹红注射液对不稳定型心绞痛患者血流动力学和高敏C反应蛋白(hs-CRP)的影响及临床疗效。方法将64例不稳定型心绞痛患者随机分为两组,对照组常规给予硝酸酯类药物、β-受体阻滞剂、抗凝、抗血小板聚集药物、血管紧张素转换酶抑制剂、他汀类药物及控制血压和/或血糖等治疗;治疗组在常规治疗基础上,加用丹红注射液30 mL加入生理盐水250 mL,静脉滴注,1次/d。两组疗程均为14 d。观察两组在治疗前后血流动力学变化和hs-CRP水平及临床疗效。结果治疗组临床疗效的总有效率为87.5%,高于对照组的65.6%(P<0.05);治疗后,治疗组血流动力学改善明显和降低hs-CRP水平有统计学意义(P<0.05)。结论丹红注射液可明显改善不稳定型心绞痛患者血流动力学指标和降低hs-CRP水平,是治疗不稳定型心绞痛安全有效的药物。 Objective To discuss the affection of hemorrheology and hs-CRP of Danhong injection on unstable angina.Methods 64 cases of such patient were divided into two groups.The control group was treated with routine method of nitrate,β-RB,anticoagulator,ACI,statins and so on.The test group was treated with Danhong injection based on routine therapy.Both group were treated twice weeks as a course.The hemorrheology and hs-CRP were observed in two groups.Results The total effective rate was 87.5% in test group and 65.6% in control group with P0.05.The hemorrheology improved and hs-CRP decreased had significant difference in two groups.Conclusion Danhong injection might improve the hemorrheology and decrease hs-CRP for such patient with effective and safe reaction.
作者 谢盛 曹聪
出处 《黑龙江医学》 2011年第9期660-662,共3页 Heilongjiang Medical Journal
关键词 丹红注射液 不稳定型心绞痛 血流动力学 高敏C反应蛋白 Danhong injection Unstable angina Hemorrheology hs-CRP
  • 相关文献

参考文献6

二级参考文献33

  • 1许涛,喻莉,郑智,李树生.丹参对实验性动脉粥样硬化形成的预防[J].临床心血管病杂志,2005,21(1):54-55. 被引量:58
  • 2莫尚武,陈恒留,刘宁,金建南,张淑渊,李文学,陈治恒,刘开明.用^(45)Ca研究红花对大鼠胸主动脉Ca^(2+)内流的影响[J].中草药,1995,26(10):532-534. 被引量:20
  • 3陈希元,马军,阿不力克木.红花黄素对大鼠动脉血浆中6-Keto-PGF_(1α)和TXB_2含量的影响[J].中国药理学通报,1996,12(6):483-483. 被引量:21
  • 4Syed IS,Sanborn TA,Rosengart TK.Therapeutic angiogenesis:a biologic bypass.Cardiology 2004; 101 (1-3):131-143.
  • 5Jiang C,Lu H,Vincent KA,et al.Gene expression profiles in human cardiac cells subjected to hypoxia or expressing a hybrid form of HIF-1 alpha.Physiol Genomics 2002; 8 (1):23-32.
  • 6Richardson RS,Wagner H,Mudaliar SR,et al.Human VEGF gene expression in skeletal muscle:effect of acute normoxic and hypoxic exercise.Am J Physiol 1999; 277:2247-2252.
  • 7Bauters C,Asahara T,Zheng LP,et al.Site-specfic therapeutic angiogenesis after systemic administration of vascular endothelial growth factor.J Vasc Surg 1995;21(2):314-324.
  • 8Bouis D,Boelens MC,Peters E,et al.Combination of vascular endothelial growth factor (VEGF) and thymidine phosphorylase (TP) to improve angiogenic gene therapy.Angiogenesis 2003 ;6(3):185-192.
  • 9Sottile J.Regulation of angiogenesis by extracellular matrix.Biochem Biophys Acta 2004; 1654(1):13-22.
  • 10Henry TD,Annex BH,McKendall GR,et al.The VIVA trial:Vascular endothelial growth factor in ischemia for vascular angiogenesis.Circulation 2003; 107(10):1359-1365.

共引文献3236

同被引文献812

引证文献10

二级引证文献246

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部